These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8052828

  • 1. [Cyclosporin in autoimmune diseases].
    Follath F, Fontana A, Leumann E, Michel BA, Miescher PA, Schreier M, Schroeder M, Wenk M.
    Schweiz Med Wochenschr; 1994 Jul 12; 124(27-28):1232-9. PubMed ID: 8052828
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine: from renal transplantation to autoimmune diseases.
    Ponticelli C.
    Ann N Y Acad Sci; 2005 Jun 12; 1051():551-8. PubMed ID: 16126995
    [Abstract] [Full Text] [Related]

  • 3. Use of cyclosporine in the treatment of autoimmune disorders.
    Favre H, Miescher PA, Lemoine R.
    Transplant Proc; 1994 Dec 12; 26(6):3194-6. PubMed ID: 7998112
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine nephropathy: pathophysiology and clinical impact.
    Shihab FS.
    Semin Nephrol; 1996 Nov 12; 16(6):536-47. PubMed ID: 9125798
    [Abstract] [Full Text] [Related]

  • 5. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
    Ferraccioli GF, Tomietto P, De Santis M.
    Ann N Y Acad Sci; 2005 Jun 12; 1051():658-65. PubMed ID: 16127006
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive therapy in management of non-malignant disease.
    Fennelly JJ, Fitzgerald MX, Fitzgerald O.
    J Ir Med Assoc; 1970 Apr 12; 63(394):141-6. PubMed ID: 5418154
    [No Abstract] [Full Text] [Related]

  • 7. Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome.
    Kano K, Kyo K, Yamada Y, Ito S, Ando T, Arisaka O.
    Clin Nephrol; 1999 Jul 12; 52(1):19-24. PubMed ID: 10442491
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 12; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 9. [Cyclosporin-A therapy in autoimmune diseases].
    Patakfalvi A.
    Orv Hetil; 1996 Sep 01; 137(35):1921-7. PubMed ID: 8927346
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experiences with cyclosporin A in patients with systemic lupus erythematosus].
    Tarr T, Zeher M, Szegedi G, Kiss E.
    Orv Hetil; 2005 Dec 04; 146(49):2485-9. PubMed ID: 16398313
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome.
    Borel JF.
    Clin Nephrol; 1991 Dec 04; 35 Suppl 1():S23-30. PubMed ID: 1860262
    [Abstract] [Full Text] [Related]

  • 12. US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
    Cush JJ, Tugwell P, Weinblatt M, Yocum D.
    J Rheumatol; 1999 May 04; 26(5):1176-86. PubMed ID: 10332987
    [Abstract] [Full Text] [Related]

  • 13. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL, Shtutman VZ, Nasonova VA.
    Klin Med (Mosk); 1994 May 04; 72(5):12-9. PubMed ID: 7853807
    [No Abstract] [Full Text] [Related]

  • 14. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
    Clin Nephrol; 2001 Feb 04; 55(2):143-8. PubMed ID: 11269678
    [Abstract] [Full Text] [Related]

  • 15. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM.
    J Nephrol; 1997 Feb 04; 10(5):266-70. PubMed ID: 9364319
    [Abstract] [Full Text] [Related]

  • 16. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 04; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 17. [Assessment of the peripheral circulation in children with nephrotic syndrome treated with cyclosporin A].
    Czupryniak A, Kałuzyńska A, Tkaczyk M, Półtorak-Krawczyk A, Ostrowski B, Wiecek B, Nowicki M.
    Przegl Lek; 2006 Jul 04; 63 Suppl 3():214-6. PubMed ID: 16898534
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients.
    Galeazzi M, Bellisai F, Manganelli S, Morozzi G, Sebastiani GD.
    Autoimmun Rev; 2006 Aug 04; 5(7):493-8. PubMed ID: 16920576
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 04; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 20. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH.
    Ann N Y Acad Sci; 2009 Sep 04; 1173():752-6. PubMed ID: 19758225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.